本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fortress Biotech Inc Series A P

7.69
-0.6568-7.87%
成交量:3,872.00
成交额:3.07万
市值:2,636.54万
市盈率:-2.86
高:8.40
开:8.40
低:7.69
收:8.35
数据加载中...
2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/27

SEC问询函

Form CORRESP - Correspondence
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/19

SEC问询函

Form CORRESP - Correspondence
2023/07/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/23

重要事件披露

Form 8-K - Current report